Pneumonitis as a consequence of (Peg)Interferon-ribavirin combination therapy for hepatitis C: A review of the literature

Digestive Diseases and Sciences

Volumn 55, Issue 3, 2010, Pages 579-585

  Slavenburg, Serena ^a   Heijdra, Yvonne F ^a   Drenth, Joost P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

(Peg)Interferon; Hepatitis C; Pneumonitis; Ribavirin; Toxicity

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; STEROID; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2B;

ADULT; BICYCLE ERGOMETRY; CASE REPORT; COUGHING; DRUG WITHDRAWAL; DYSPNEA; FEVER; HEPATITIS C; HUMAN; IMAGE ANALYSIS; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; LIVER FUNCTION TEST; LUNG INJURY; LUNG LAVAGE; MALE; MEDICAL LITERATURE; MEDLINE; MORTALITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; VIRUS LOAD; AGED; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; FEMALE; INTERSTITIAL LUNG DISEASE; MIDDLE AGED;

AGED; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN;

EID: 77949320438     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0797-1     Document Type: Review

References (30)

1. JH Hoofnagle L Seeff 2006 Peginterferon and ribavirin for chronic hepatitis C N Engl J Med 355 2444 2451 10.1056/NEJMct061675 10.1056/NEJMct061675 1:CAS:528:DC%2BD28Xht12nt7%2FK 17151366 (Pubitemid 44903748)
2. GM Lauer BD Walker 2001 Hepatitis C virus infection N Engl J Med 345 41 52 10.1056/NEJM200107053450107 10.1056/NEJM200107053450107 1:STN:280: DC%2BD3MzosFGrug%3D%3D 11439948 (Pubitemid 32634271)
3. HL Janssen L Berk M Vermeulen SW Schalm 1990 Seizures associated with low-dose alpha-interferon Lancet 336 1580 10.1016/0140-6736(90)93356-T 10.1016/0140-6736(90)93356-T 1:STN:280:DyaK3M%2Fntl2msg%3D%3D 1979391
4. MW Fried 2002 Side effects of therapy of hepatitis C and their management Hepatology 36 S237 S244 10.1002/hep.1840360730 10.1002/hep.1840360730 12407599
5. G Fattovich G Giustina S Favarato A Ruol 1996 A survey of adverse events in 11, 241 patients with chronic viral hepatitis treated with alfa interferon J Hepatol 24 38 47 10.1016/S0168-8278(96)80184-X 10.1016/S0168-8278(96)80184-X 1:STN:280:DyaK28vjtV2nsw%3D%3D 8834023 (Pubitemid 26037204)
6. K ShivaKumar MW Russo AC Borczuk M Brown SP Esposito SJ Lobritto IM Jacobson RS Brown Jr 2002 Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C Am J Gastroenterol 97 2432 2440 10.1111/j.1572-0241.2002.05999.x 10.1111/j.1572-0241.2002.05999.x
7. J Midturi M Sierra-Hoffman D Hurley R Winn R Beissner J Carpenter 2004 Spectrum of pulmonary Toxicity associated with use of interferon therapy for hepatitis C. Case report and review of literature Clin Infect Dis 39 1724 1729 10.1086/425746 10.1086/425746 15578378 (Pubitemid 39578553)
8. T Okanoue S Sakamoto Y Itoh M Minami K Yasui M Sakamoto K Nishioji T Katagishi Y Nakagawa H Tada Y Sawa M Mizuno K Kagawa K Kashima 1996 Side effects of high-dose interferon therapy for chronic hepatitis C J Hepatol 25 283 291 10.1016/S0168-8278(96)80113-9 10.1016/S0168-8278(96)80113-9 1:CAS:528: DyaK28Xmtleisrw%3D 8895006 (Pubitemid 26323465)
9. T Kamisako Y Adachi J Chihara T Yamamoto 1993 Interstitial pneumonitis and interferon-alfa BMJ 306 896 10.1136/bmj.306.6882.896-c 1:STN:280: DyaK3s3lvVSjtg%3D%3D 8490417
10. K Chin C Tabata N Sataka S Nagai F Moriyasu K Kuno 1994 Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C Chest 105 939 941 10.1378/chest.105.3.939 10.1378/chest.105.3.939 1:STN:280:DyaK2c7nvVSgtw%3D%3D 8131569 (Pubitemid 24088489)
11. N Hizawa J Kojima T Kojima N Sukoh E Yamaguchi Y Kawakami T Matsushima 1994 A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration Intern Med 33 337 341 10.2169/internalmedicine. 33.337 10.2169/internalmedicine.33.337 1:STN:280:DyaK2M%2FgtleisA%3D%3D 7919619 (Pubitemid 24235318)
12. T Ishizaki F Sasaki S Ameshima K Shiozaki H Takahashi Y Abe S Ito M Kuriyama T Nakai M Kitagawa 1996 Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis Eur Respir J 9 2691 2696 10.1183/09031936.96.09122691 10.1183/09031936.96.09122691 1:STN:280: DyaK2s7jsFCmsw%3D%3D 8980988 (Pubitemid 26407927)
13. K Moriya K Yasuda K Koike Y Ichinose H Yotsuyanagi K Kurokawa S Iino 1994 Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C J Gastroenterol 29 514 517 10.1007/BF02361253 10.1007/BF02361253 1:STN:280:DyaK2M%2FjvFGltg%3D%3D 7951865 (Pubitemid 24262724)
14. S Abi-Nassif EJ Mark RB Fogel RK Hallisey Jr 2003 Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS Chest 124 406 410 10.1378/chest.124.1.406 10.1378/chest.124.1.406 12853555 (Pubitemid 36851384)
15. V Fuhrmann L Kramer E Bauer H Laferl G Tucek G Dekan P Schenk 2004 Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection Dig Dis Sci 49 1966 1970 10.1007/s10620-004-9602-3 10.1007/s10620-004-9602-3 15628735 (Pubitemid 40228570)
16. R Carrillo-Esper D González-Avila M Uribe-Ríos N Méndez-Sánchez 2008 Interstitial pneumonitis associated with pegylated interferon alpha-2b therapy for chronic hepatitis C. Case report Ann Hepatol 7 87 90 18376374 (Pubitemid 351468545)
17. AE Hillier J Mand A Raza M Markov A Nadir 2006 Consensus interferon induced interstitial pneumonitis in a patient with HCV Am J Gastroenterol 101 200 202 10.1111/j.1572-0241.2005.50006-9.x 10.1111/j.1572-0241.2006.00393-3.x 16405558 (Pubitemid 43381733)
18. C Renou S Germain A Harafa S Martin O Larroque P Muller JJ Bertrand P Halfon 2005 Pneumonia recurrence during chronic hepatitis C treatment Am J Gastroenterol 100 1625 1626 10.1111/j.1572-0241.2005.50006-9.x 10.1111/j.1572-0241.2005.50006-9.x 15984999 (Pubitemid 41032379)
19. KS Rothfuss JC Bode 2002 Interstitial pneumonitis during combination therapy with interferon-α and ribavirin in a patient with chronic hepatitis C Z Gastroenterol 40 807 810 10.1055/s-2002-33879 10.1055/s-2002-33879 1:CAS:528:DC%2BD38Xoslyjur4%3D 12215950
20. YC Chen SN Lu MC Lin 2007 Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C Chang Gung Med J 30 92 97 1:CAS:528:DC%2BD2sXhtFakt73P 17477035 (Pubitemid 46594840)
21. BK Son JH Sohn TY Kim YK Park YC Jeon DS Han 2007 Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C Korean J Hepatol 13 103 107 17380081
22. P Rocca J Dumortier P Tanière S Duperret T Vial V Cottin B Delafosse JY Scoazec O Boillot 2002 Induced interstitial pneumonitis: role of pegylated interferon alpha 2b Gastroenterol Clin Biol 26 405 408 12070414 (Pubitemid 34555813)
23. RR Nemivant R Hammadeh N Shah J Villanueva 2003 Interstitial pneumonitis due to pegylated interferon alfa-2b and ribavirin Chest 124 242S 10.1378/chest.124.1.242 10.1378/chest.124.1.242 (Pubitemid 36851358)
24. JS Park KS Lee JS Kim CS Park YL Suh DL Choi KJ Kim 1995 Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients Radiology 195 645 648 1:STN:280:DyaK2M3ntlGmtA%3D%3D 7753988
25. DB Strader T Wright DL Thomas 2004 Diagnosis, management, and treatment of hepatitis C Hepatology 39 1147 1171 10.1002/hep.20119 10.1002/hep.20119 15057920 (Pubitemid 38428955)
26. V Tahan F Ozseker D Guneylioglu A Baran R Ozaras A Mert AC Ucisik T Cagatay D Yilmazbayhan H Senturk 2003 Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature Dig Dis Sci 48 169 173 10.1023/A:1021759120428 10.1023/A:1021759120428 1:STN:280: DC%2BD3s7jtFaktg%3D%3D 12645805 (Pubitemid 36232777)
27. Japanese Welfare Ministry. Report on drug side effect. No. 125, 1994.
28. Abbas AK, Lichtman AH, Pober JS. Effector mechanisms of immune responses. In: Cellular and molecular immunology. 3rd ed. Philadelphia: WB Saunders; 1997:245-338.
29. EC Borden D Parkinson 1998 A perspective on the clinical effectiveness and tolerance of interferon alpha Semin Oncol 25 3 8 1:CAS:528: DyaK1cXhsVKis74%3D 9482534 (Pubitemid 28093149)
30. H Tilg 1997 New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine Gastroenterology 112 1017 1021 10.1053/gast.1997.v112.pm9041265 10.1053/gast.1997.v112.pm9041265 1:CAS:528:DyaK2sXhvFOlsLY%3D 9041265 (Pubitemid 27113829)